Cost of healthcare for patients with migraine in five European countries: Results from the International Burden of Migraine Study (IBMS)

Journal of Headache and Pain

Volumn 13, Issue 5, 2012, Pages 361-378

  Bloudek, L M ^a   Stokes, M ^b   Buse, D C ^c   Wilcox, T K ^b   Lipton, R B ^c   Goadsby, P J ^d   Varon, S F ^a   Blumenfeld, A M ^e   Katsarava, Z ^f   Pascual, J ^g   Lanteri Minet, M ^h   Cortelli, P ^i,j   Martelletti, P ^k  

^a ALLERGAN INC   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Neurology Center   (United States)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^h University of Côte d'Azur   (France)

ⁱ IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

Chronic migraine; Cost; Episodic migraine; France; Germany; Italy; Migraine; Resource utilization; Spain; United Kingdom

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; DISABILITY; EMERGENCY CARE; EPISODIC MIGRAINE; FEMALE; FRANCE; GERMANY; HEALTH CARE COST; HOSPITAL CARE; HUMAN; INFORMATION PROCESSING; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; SPAIN; TRANSFORMED MIGRAINE; UNITED KINGDOM;

CROSS-SECTIONAL STUDIES; DISABLED PERSONS; EUROPE; FEMALE; HEALTH CARE COSTS; HEALTH SURVEYS; HUMANS; MALE; MIGRAINE DISORDERS;

EID: 84865357404     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-012-0460-7     Document Type: Article

References (59)

1. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988-994 (Pubitemid 29442114)
2. World Health Organization (2004) Headache disorders. http://www.who.int/ mediacentre/factsheets/fs277/en/. Accessed July 2010
3. Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289-299
4. Stovner LJ, Andree C, Eurolight Steering Committee (2008) Impact of headache in Europe: a review for the Eurolight project. J Headache Pain 9(3):139-146
5. Mennini FS, Gitto L, Martelletti P (2008) Improving care through health economics analyses: cost of illness and headache. J Headache Pain 9(4):199-206
6. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby P, Gobel H, Lainez M, Lance J, Lipton R, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742-746
7. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: a field study of revised IHS criteria. Neurology 47:871-875
8. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache 48:1157-1168
9. Reed ML, Buse DC, Manack AN, Fanning KM, Serrano D, Turkel CC, Lipton RB (2011) Prevalence of chronic migraine (CM), headache-related disability and sociodemographic factors in the US population. Headache 51(S1):28
10. Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L, Lipton R (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30:599-609
11. Kavuk I, Cetindere U, Agelink MW, Diener HC (2003) Epidemiology of chronic daily headache. Eur J Med Res 8(6):236-240
12. Bigal ME, Rapoport AM, Lipton RB et al (2003) Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) questionnaire. A comparison of chronic migraine with episodic migraine. Headache 3:336-342 (Pubitemid 36417763)
13. Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71(8):559-566
14. Buse DC, Manack AN, Serrano D, Varon SF, Turkel CC, Lipton RB (2012) Headache-impact of chronic and episodic migraine: results from the AMPP study. Headache 52(1):3-17
15. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81(4):428-432
16. Meletiche DM, Lofland JH, Young WB (2001) Quality of life differences between patients with episodic and transformed migraine. Headache 41:573-578 (Pubitemid 32619261)
17. Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB (2010) Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med 52(1):8-14
18. Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, Manack A, Proskorovsky I, Gladstone J, Buse DC, Varon SF, Goadsby PJ, Blumenfeld AM (2011) Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache 51(7):1058-1077
19. Guitera V, Munöz P, Castillo J, Pascual J (2002) Quality of life in chronic daily headache: a study in a general population. Neurology 58(7):1062-1065 (Pubitemid 34298546)
20. Colás R, Munöz P, Temprano R, Gómez C, Pascual J (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62(8):1338-1342 (Pubitemid 38526046)
21. Antonaci F, Dumitrache C, De Cillis I, Allena M (2010) A review of current European treatment guidelines for migraine. J Headache Pain 11:13-19
22. Michel P, Auray J, Chicoye A, Dartigues J, Lamure M, Duru G, Henry P, Salamon R (1993) Prise en charge des migraineux en France: coût et recours aux soins. J d'Econ Méd 11:71-80 (Pubitemid 23245381)
23. Neubauer G, Ujlaky R (2002) Migraine-a disease and its costs. Pharm Unserer Zeit 31:494-497
24. van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FF (1995) Societal perspective on the burden of migraine in The Netherlands. Pharmacoeconomics 7:170-179
25. Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12(Suppl. 1):59-62 (Pubitemid 40755606)
26. Payne KA, Varon SF, Kawata AK, Yeomans K, Wilcox TK, Manack A, Buse DC, Goadsby PJ, Lipton RB, Blumenfeld AM (2011) The International Burden of Migraine Study (IBMS): study design, methodology and baseline cohort characteristics. Cephalalgia 31:1116-1130
27. Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 56(6 Suppl 1):S20-S28 (Pubitemid 32240082)
28. Stewart WF, Lipton RB, Kolodner K (2003) Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms. Headache 43(3):258-265 (Pubitemid 36348773)
29. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19:107-114 (Pubitemid 29170106)
30. Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 31(3):301-315
31. AMELI (2010) L'Assurance maladie en ligne. http://www.ameli. fr. Accessed May 2010
32. Kassenarztliche Bundesvereinigung (2010) Einheitlicher Bewertungsmassstab (EBM). http://www.kbv.de/8144.html. Accessed March 2010
33. Department of Health (2010) Publications and Statistics NHS Reference Costs 2007-2008. http://www.dh.gov.uk/en/Publicationsan dstatistics/index.htm. Accessed May 2010
34. PSSRU (2011) Unit Costs of Health and Social Care 2007 http://www.pssru.ac.uk/uc/uc2007contents.htm#contents. Accessed May 2011
35. Ministero della Salute (2008) Tariffa euro in vigore da prenotazioni, Lombardia (unpublished
36. Diario Oficial de Galicia, núm 199 del 9 de octubre 2009, pg 15997
37. Boletín Oficial del País Vasco, núm. 69 del 14 de abril del 2009
38. Boletín Oficial de la Junta de Andalucía, núm. 210 del 27 de octubre de 2005, pg 46
39. Diari Oficial de la Comunitat Valenciana, núm 5922 de 29 de diciembre del 2008, pg 93310
40. Curepoint (2010) Acupuncture in Bristol. http://www.curepoint. co.uk/acupuncture-fees.shtml. Accessed May 2010
41. Energetique Traditionnelle Chinoise (2010) http://www.energetiq uechinoise.com/index.php?id=1#acupuncture. AccessedMay 2010
42. Consumer Eroski (2010) La acupunctura. http://www.consumer.es/web/es/ salud/investigacion-medica/2004/06/14/104193.php. Accessed May 2010
43. EUMed.it (2010) Tariffa Unica Convenzionale per le Prestazioni di Assistenza Ospedaliera per Acuti 2006. http://www.eumed.it/drg/TUC-2006.pdf. Accessed May 2010
44. InEK -Institut für das Entgeltsystem im Krankenhaus (2010) G-DRG -System 2010. http://www.g-drg.de/cms/index.php/inek-site-de/G-DRG-System-2010. Accessed March 2010
45. Registro de Altas de los Hospitales Generales del Sistema Nacional de Salud. CMBD (2010) Norma Estatal 2007 Ministerio de Sanidad y Politica Social. http://www.msc.es/estadEstudios/estadisticas/cmbd.htm. Accessed April 2010
46. Williams AE, Lloyd AC, Watson L, Rabe KF (2006) Cost of scheduled and unscheduled asthma management in seven European Union countries. Eur Respir Rev 15:1-9
47. British National Formulary v58 (2010) http://bnf.org/bnf. Accessed May 2010
48. Nomenclátor de Facturación (2010) Ministerio de Sanidad y Politica Social de Espanä. http://www.msps.es/profesionales/farmacia/ frmNomenclator.jsp. Accessed April 2010
49. Rote list (2010) http://www.rote-liste.de. Accessed March 2010
50. Pneumonet (2010) Area Scientifica. Prontuario. http://www.pneum onet.it/scientifico/prontuario/. Accessed May 2010
51. Consulting Room (2010) Vistabel information and background. http://www.consultingroom.com/Treatment-FAQs/Product-Display.asp?Product-ID= 98&Vistabel. Accessed May 2010
52. Ophthalmologic Centre for Diagnosis and Treatment (2010) http://www.ophtalmo-centre.fr/eng/techniques/esthetics.htm. Accessed May 2010
53. Nagy AJ, Gandhi S, Bhola R, Goadsby PJ (2011) Intravenous dihydroergotamine (DHE) for inpatient management of refractory primary headaches. Neurology 77:1827-1832
54. Afridi SK, Shields KG, Bhola R, Goadsby PJ (2006) Greater occipital nerve injection in primary headache syndromes -prolonged effects from a single injection. Pain 122:126-129
55. Berg J (2004) Economic evidence in migraine and other headaches: a review. Eur J Health Econ 5(Suppl 1):S43-S54
56. Pradalier A, Auray JP, El Hasnaoui A, Alzahouri K, Dartigues JF, Duru G, Henry P, Lantéri-Minet M, Lucas C, Chazot G, Gaudin AF (2004) Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study. Pharmacoeconomics 22(15):985-999 (Pubitemid 39472624)
57. Badia X, Magaz S, Gutiérrez L, Galván J (2004) The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics 22(9):591-603 (Pubitemid 38943104)
58. Linde M, Gustavsson A, Stovner LJ et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19(5):703-711
59. Lipton RB, StewartWF, Diamond S, DiamondML, ReedM(2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41(7):646-657 (Pubitemid 32777747)